GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $107,000 | +8.1% | 3,336 | +24.6% | 0.00% | – |
| Q1 2022 | $99,000 | +4.2% | 2,677 | -18.2% | 0.00% | – |
| Q4 2021 | $95,000 | +13.1% | 3,271 | 0.0% | 0.00% | – |
| Q3 2021 | $84,000 | -26.3% | 3,271 | 0.0% | 0.00% | – |
| Q2 2021 | $114,000 | -13.6% | 3,271 | 0.0% | 0.00% | – |
| Q1 2021 | $132,000 | -25.4% | 3,271 | -20.0% | 0.00% | – |
| Q4 2020 | $177,000 | -21.3% | 4,087 | 0.0% | 0.00% | – |
| Q3 2020 | $225,000 | -12.5% | 4,087 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $257,000 | +23.0% | 4,087 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $209,000 | -35.3% | 4,087 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $323,000 | -17.4% | 4,087 | -45.1% | 0.00% | 0.0% |
| Q2 2019 | $391,000 | +9.5% | 7,451 | +10.2% | 0.00% | 0.0% |
| Q1 2019 | $357,000 | +33.2% | 6,763 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $268,000 | +41.8% | 6,763 | +36.1% | 0.00% | – |
| Q3 2018 | $189,000 | -15.6% | 4,969 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $224,000 | +32.5% | 4,969 | +42.0% | 0.00% | – |
| Q1 2018 | $169,000 | +23.4% | 3,500 | 0.0% | 0.00% | – |
| Q4 2017 | $137,000 | +33.0% | 3,500 | 0.0% | 0.00% | – |
| Q3 2017 | $103,000 | +7.3% | 3,500 | 0.0% | 0.00% | – |
| Q2 2017 | $96,000 | -25.6% | 3,500 | 0.0% | 0.00% | – |
| Q1 2017 | $129,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |